Ferreira David, Hardy Jack, Meere William, Butel-Simoes Lloyd, Sritharan Shanathan, Ray Max, French Matthew, McGee Michael, O'Connor Simon, Whitehead Nicholas, Turner Stuart, Healey Paul, Davies Allan, Morris Gwilym, Jackson Nicholas, Barlow Malcolm, Ford Tom, Leask Sarah, Oldmeadow Christopher, Attia John, Sverdlov Aaron, Collins Nicholas, Boyle Andrew, Wilsmore Bradley
Cardiovascular Department, John Hunter Hospital, Lookout Road, New Lambton Heights, Newcastle, 2305, Australia.
School of Medicine and Public Health, Newcastle University, University Drive, Callaghan, Newcastle, 2308, Australia.
Eur Heart J. 2024 Dec 16;45(47):4990-4998. doi: 10.1093/eurheartj/ehae573.
Current guidelines recommend 6 h of solid food and 2 h of clear liquid fasting for patients undergoing cardiac procedures with conscious sedation. There are no data to support this practice, and previous single-centre studies support the safety of removing fasting requirements. The objective of this study was to determine the non-inferiority of a no-fasting strategy to fasting prior to cardiac catheterization procedures which require conscious sedation.
This is a multicentre, investigator-initiated, non-inferiority, randomized trial conducted in Australia with a prospective open-label, blinded endpoint design. Patients referred for coronary angiography, percutaneous coronary intervention, or cardiac implantable electronic device (CIED)-related procedures were enrolled. Patients were randomized 1:1 to fasting as normal (6 h solid food and 2 h clear liquid) or no-fasting requirements (encouraged to have regular meals but not mandated to do so). Recruitment occurred from 2022 to 2023. The primary outcome was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia assessed with a Bayesian approach. Secondary outcomes included patient satisfaction score, new ventilation requirement (non-invasive and invasive), new intensive care unit admission, 30-day readmission, 30-day mortality, 30-day pneumonia.
A total of 716 patients were randomized with 358 in each group. Those in the fasting arm had significantly longer solid food fasting (13.2 vs. 3.0 h, Bayes factor >100, indicating extreme evidence of difference) and clear liquid fasting times (7.0 vs. 2.4 h, Bayes factor >100). The primary composite outcome occurred in 19.1% of patients in the fasting arm and 12.0% of patients in the no-fasting arm. The estimate of the mean posterior difference in proportions with credibility interval (CI) in the primary composite outcome was -5.2% (95% CI -9.6 to -.9), favouring no fasting. This result confirms the non-inferiority (posterior probability >99.5%) and superiority (posterior probability 99.1%) of no fasting for the primary composite outcome. The no-fasting arm had improved patient satisfaction scores with a posterior mean difference of 4.02 points (95% CI 3.36-4.67, Bayes factor >100). Secondary outcome events were observed to be similar.
In patients undergoing cardiac catheterization and CIED-related procedures, no fasting was non-inferior and superior to fasting for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Patient satisfaction scores were significantly better with no fasting. This supports removing fasting requirements for patients undergoing cardiac catheterization laboratory procedures that require conscious sedation.
当前指南建议,接受心脏手术并采用清醒镇静的患者需禁食6小时固体食物、禁饮2小时清亮液体。但并无数据支持这一做法,且既往单中心研究支持取消禁食要求的安全性。本研究的目的是确定在需要清醒镇静的心脏导管插入术之前,不禁食策略相对于禁食策略的非劣效性。
这是一项在澳大利亚开展的多中心、研究者发起的非劣效性随机试验,采用前瞻性开放标签、盲法终点设计。纳入因冠状动脉造影、经皮冠状动脉介入治疗或心脏植入式电子设备(CIED)相关手术而转诊的患者。患者按1:1随机分为正常禁食组(禁食6小时固体食物、禁饮2小时清亮液体)或不禁食组(鼓励正常饮食但不强制)。招募时间为2022年至2023年。主要结局是采用贝叶斯方法评估的吸入性肺炎、低血压、高血糖和低血糖的复合结局。次要结局包括患者满意度评分、新的通气需求(无创和有创)、新的重症监护病房入住、30天再入院、30天死亡率、30天肺炎。
共716例患者被随机分组,每组358例。禁食组患者的固体食物禁食时间显著更长(13.2小时对3.0小时,贝叶斯因子>100,表明差异有极显著证据),清亮液体禁食时间也更长(7.0小时对2.4小时,贝叶斯因子>100)。主要复合结局在禁食组患者中的发生率为19.1%,在不禁食组患者中的发生率为12.0%。主要复合结局中比例的平均后验差异估计值及可信区间(CI)为-5.2%(95%CI -9.6至-0.9),支持不禁食。这一结果证实了不禁食对于主要复合结局的非劣效性(后验概率>99.5%)和优越性(后验概率99.1%)。不禁食组患者满意度评分有所提高,后验平均差异为4.02分(95%CI 3.36 - 4.67,贝叶斯因子>100)。观察到次要结局事件相似。
在接受心脏导管插入术和CIED相关手术的患者中,对于吸入性肺炎、低血压、高血糖和低血糖的主要复合结局,不禁食非劣于且优于禁食。不禁食时患者满意度评分显著更高。这支持取消对接受需要清醒镇静的心脏导管插入实验室手术患者的禁食要求。